T cell sensitivity to antigen is intrinsically regulated during maturation to ensure proper development of immunity and tolerance, but how this is accomplished remains elusive. Here we show that increasing miR-181a expression in mature T cells augments the sensitivity to peptide antigens, while inhibiting miR-181a expression in the immature T cells reduces sensitivity and impairs both positive and negative selection. Moreover, quantitative regulation of T cell sensitivity by miR-181a enables mature T cells to recognize antagonists-the inhibitory peptide antigens-as agonists. These effects are in part achieved by the downregulation of multiple phosphatases, which leads to elevated steadystate levels of phosphorylated intermediates and a reduction of the T cell receptor signaling threshold. Importantly, higher miR-181a expression correlates with greater T cell sensitivity in immature T cells, suggesting that miR-181a acts as an intrinsic antigen sensitivity ''rheostat'' during T cell development.
INTRODUCTION
One of the key features of a functioning immune system is its ability to distinguish antigens of foreign origin from those derived endogenously and to mount an immune response against the former. With respect to T cells, this goal is achieved through antigen recognition by T cell receptors (TCRs) and a highly ordered developmental process in the thymus. TCRs constantly sample a diverse set of self and foreign peptide antigens presented in major histocompatibility complexes (MHCs) on the surface of antigen presenting cells (APCs), and these interactions elicit discrete intracellular signals and T cell responses. The mature T cell's response to antigen is largely dictated by the binding characteristics of its TCR for a given peptide-MHC complex (pMHC) (Kersh and Allen, 1996) . In general, pMHC ligands with slower dissociation rates produce stronger TCR signals and lead to higher T cell reactivity to the antigenic peptides (Davis et al., 1998; Holler and Kranz, 2003) . Typically, the most stable pMHC complexes with respect to TCR binding are agonists, while the less stable variants are weak agonists and then antagonists Wu et al., 2002) , which are not able to activate T cells more than partially themselves (Sumen et al., 2004) and also block responses to agonist ligand (De Magistris et al., 1992) . Although a number of models have been proposed to explain this kinetic discrimination in T cell activation (McKeithan, 1995; Rabinowitz et al., 1996) , exactly how T cells sense quantitative changes in antigenic peptide affinities through their TCRs and produce both quantitatively and qualitatively different responses remains an intensive area of study.
In addition, T cell responsiveness and TCR signaling to a specific ligand also vary with different developmental stages, suggesting that T cell sensitivity to antigens is intrinsically regulated during development (Davey et al., 1998) . For example, in immature CD4 + CD8 + doublepositive (DP) thymocytes, low affinity antigenic peptides that are unable to activate mature effector T cells are sufficient to induce strong activation and clonal deletion (Pircher et al., 1991) ; antagonists that are normally inhibitory to effector T cells can induce positive selection (Hogquist et al., 1994 ). These observations demonstrate that T cell sensitivity is intrinsically regulated to ensure proper development of specificity and sensitivity to foreign antigens while avoiding self recognition. However, (D) in response to a defined number of agonist MCC peptides. In the top left are peptide images representing the integrated intensity of six MCC peptides at the T cell and APC (T:APC) interface. Shown in the bottom left is relative cytosolic calcium concentration as a function of time after stimulation, as measured from ratioed fura-2 images; the arrow indicates the time point at which the peptide image was taken. In the top right are overlaid differential interference contrast (DIC) images and ratioed calcium images taken at different time points after stimulation. In the bottom right are corresponding ratioed calcium images. Fluorescence intensity of the calcium signal is represented in a false color scale.
little is known about how intrinsic molecular programs influence this sensitivity.
Recent studies suggest that microRNA (miRNA)-mediated gene regulation may represent a fundamental layer of posttranscriptional genetic programs in metazoan genomes that has broad effects on gene expression (Ambros, 2003; Bartel, 2004) . These $22 nt RNAs can repress the expression of protein-coding genes by targeting cognate messenger RNAs for degradation or translational repression (Ambros, 2003; Bartel and Chen, 2004) . Many miRNAs are differentially regulated in hematopoietic lineages, and some have been shown to play roles in controlling the development of immune cells Fazi et al., 2005) . However, the role of miRNAs in the adaptive immune response is largely unknown.
RESULTS

Dynamic Regulation of miR-181a Expression during T Cell Development
Among many known hematopoietic miRNAs, miR-181a was shown to have a role in B and T cell differentiation when ectopically expressed in hematopoietic stem/progenitor cells . Interestingly, miR-181a is also strongly expressed in the mouse thymus. To characterize the role of miR-181a in T cells, we examined how miR-181a expression is regulated during T cell development and maturation. T cell differentiation in the thymus can be divided into discrete stages characterized by the expression of CD4 and CD8 coreceptors. CD4 and CD8 double-negative (DN) cells, which are the early T cell progenitors, can differentiate into CD4 and CD8 DP cells and then CD4 or CD8 single-positive (SP) cells. DN ) cell populations, in the order of their appearance during development. We purified these populations by FACS sorting according to surface marker expression. We also obtained CD4 + naïve T cells from the lymph nodes of Rag2À/À 5C.C7 TCR transgenic mice and derived Th1 and Th2 effector cells. Analysis of miR-181a expression in these populations revealed a dynamic regulation of miR-181a expression during T cell maturation ( Figure 1A ). miR-181a expression is high in the early T cell differentiation stages ranging from approximately 427 to 858 to 1077 copies/cell in the DN1-3 cell populations, respectively. Its expression then drops sharply to $225, 141, 42, and 14 copies/cell in DN4, DP, CD4 SP, and CD8 SP thymocytes. We also noticed a further decrease to $29 copies/cell in naïve cells, and $12 and $8 copies/cell in Th1 and Th2 cells ( Figure 1A) . Notably, when comparing to effector T cells and taking into account that DP cells are much smaller in size, miR-181a expression is significantly higher in DP cells, which are more sensitive to pMHCs with low or intermediate affinities. In comparison, miR-142-3p, a hematopoietic-specific miRNA , has distinct expression patterns during T cell development and maturation ( Figure S1A ). The dynamic regulation of miR-181a expression indicates that miR-181a may play a role in T cell maturation. Indeed, using an OP9-DL1 stromal cell and thymocyte coculture assay (Schmitt et al., 2004) , we have shown that ectopic expression of miR181a in DN thymocytes causes a quantitative increase in the percentage of DP cells and a decrease in the proportion of CD8 + SP cells (H.M., T. Mao, and C.-Z.C., unpublished data), suggesting that miR-181a can influence the development of thymic progenitor cells during both pre-TCR and TCR-dependent stages.
miR-181a Augments TCR Signaling Strength
To investigate miR-181a's role in antigen recognition, we assessed its effect on TCR signaling in antigen-primed CD4 + T cells. We increased the expression of miR-181a in primed T cells derived from 5C.C7 TCR transgenic mice by retroviral transduction ( Figure S2A ), and this resulted in an approximately 3-to 5-fold elevation in miR181a levels ( Figure 1B) . T cells were then stimulated with CH27 APCs preloaded with a nonsaturating amount of agonist peptide derived from Moth Cytochrome C (MCC, amino acids 88-103), and then TCR signaling strength was assessed by measuring calcium elevation using video microscopy and ratio imaging. Elevated miR-181a expression in T cells resulted in a substantial increase in intracellular calcium upon stimulation by MCC, whereas mutations in the 5 0 two and three nucleotides of miR181a reduced this activity nearly to the basal level (Figure S3) . Furthermore, miR-181a expression in T cells increased IL-2 production by 2-fold compared to the control ( Figure 2D ). These results show that increased miR-181a expression augments TCR-mediated T cell activation.
We then measured the effects of miR-181a on TCR signal output at the single cell level (Figures 1C and 1D ; Movies S1 and S2). The TCR signal input is defined as the number of antigenic pMHC complexes at the T:APC interface, and the output is measured as the calcium concentration changes in the T cell cytosol (Irvine et al., 2002; Li et al., 2004; Purbhoo et al., 2004) . In T cells infected with control virus (control T cells), approximately five MCC peptides are needed to produce a half-maximal calcium response (EC50) ( Figures 1C and 1E ). This response is essentially identical to that of uninfected T cells (Irvine et al., 2002; Li et al., 2004) , suggesting that viral infection did not cause discernable changes in TCR signaling. In comparison, T cells transduced with the miR-181a construct (miR-181a T cells) require only approximately two MCC peptides to reach the EC50 ( Figures 1D and 1E) , showing that miR-181a expression increases T cell sensitivity by more than 2-fold. Also notable is that signal output in miR-181a T cells is about 40% higher than that in control T cells, as indicated by the plateau calcium flux ( Figure 1E ). The effects of miR-181a may be understated in this measurement since MCC is a strong agonist and may allow little room for further improvement. Indeed, a more dramatic increase was observed when miR-181a T cells were challenged with a weak agonist, MCC 102S ( Figure 1F ). These observations demonstrate that miR-181a expression in mature T cells augments both the strength and sensitivity of TCR signaling to strong and weak agonists.
miR-181a Converts Antagonists into Agonists
In addition to these quantitative changes in T cell sensitivity, we also explored whether miR-181a could alter antigen discrimination and allow T cells to respond to antagonists. Under standard test conditions, when the antagonist MCC 99R is present in large excess to the agonist (Sumen et al., 2004) , TCR signaling is blocked in control T cells-where no calcium influx was detected ( Figure 2A ). Interestingly, under the same conditions, TCR signaling is not blocked in miR-181a T cells, demonstrating that miR-181a overrides TCR antagonism ( Figure 2A ; Movie S3). Since we have shown that miR-181a expression can augment the TCR response to agonists (Figure 1 ), it was possible that this reversal of antagonist function simply is the result of increased agonist responses beyond the ability of antagonist to block. However, when T cells were challenged with antagonist alone, we found that MCC 99R can stimulate a calcium response in miR-181a T cells, demonstrating that miR-181a expression enables T cells to recognize the normally inhibitory antagonist as an agonist ( Figure 2B ; Movie S4). MCC 99R stimulation resulted in a more than 2-fold increase of calcium in the peak response and sustained elevation for more than 10 min, indicating that the antagonist induces a full-scale response in these cells ( Figure 2C ).
Furthermore, we examined whether MCC 99R can stimulate effector T cell function. In miR-181a T cells, MCC 99R is able to stimulate IL-2 production ( Figure 2D ) and T cell proliferation ( Figure 2E ), although somewhat more weakly than the responses generated by MCC in control cells. Moreover, this dramatic functional switch is not limited just to MCC 99R: similar results are seen with another antagonist, MCC 102G ( Figures 2F and 6E ). Taken together, these results show that ectopic miR-181a expression not only quantitatively enhances T cell signaling strength and TCR sensitivity to antigens but also leads to a qualitative switch and enables them to respond to antagonists.
miR-181a Represses Multiple Negative Regulators in the TCR Signaling Pathway
To understand how miR-181a influences T cell reactivity, we first examined whether miR-181a regulates the expression of 5C.C7 TCR or other surface molecules that are known to play important roles in TCR signaling. miR181a expression does not change TCR density on the cell surface based on FACS analysis ( Figure S4A ). Furthermore, there is no discernable difference in surface CD4 levels ( Figure S4A ), thus eliminating the possibility that miR-181a augments T cell sensitivity by altering CD4 coreceptor expression (Irvine et al., 2002; Li et al., 2004) . Interestingly, we did detect an increase in the costimulatory molecule CD28 and a decrease in its antagonistic partner CTLA-4 on miR-181a T cells ( Figure S4B ). Modulating the expression of costimulatory molecules by miR-181a seems to have a positive effect on TCR signal strength as indicated by sustained calcium flux ( Figures S4C and  S4D ), which may have contributed to the plateau elevation observed in Figure 1E . However, miR-181a T cells can still respond to MCC 99R while costimulation is inhibited by antibody blockade of CD28 ligands (B7.1 and B7.2) on the APCs' surface, indicating that miR181a's effect on costimulation does not contribute to the conversion of antagonists to agonists ( Figure S5 ; Movie S5). Thus, miR181a is more likely to modulate TCR sensitivity to antigens by controlling the expression of intracellular signaling molecules.
By challenging T cell clones bearing two distinct TCRs with their respective peptide agonist and antagonist, several studies have shown that antagonists elicit negative signals that can actively repress the agonist-induced responses from the other TCR (Dittel et al., 1999) . The tyrosine phosphatase SHP-1 has been proposed to be the negative feedback regulator triggered by antagonists, and the activation of ERK kinases appears to override this suppression (Dittel et al., 1999; Stefanova et al., 2003; Altan-Bonnet and Germain, 2005) . However, our computational analysis does not shown any putative miR-181a binding sites in the SHP-1 mRNA. Furthermore, miR-181a expression in T cells does not alter SHP-1 protein ( Figure 3B ) or RNA level ( Figure 3C ). Thus, SHP-1 is not a direct target of miR-181a, suggesting that other components of the T cell signaling pathway may contribute to antagonism.
Since a number of tyrosine and serine phosphatases besides SHP-1 have been implicated in the suppression of TCR signaling (Mustelin et al., 2005) , we examined potential miR-181a target sites in the phosphatases that might be involved in TCR proximal signaling (nonreceptor type tyrosine phosphatases, PTPNs) or ERK dephosphorylation (dual specificity phosphatases, DUSPs). We searched for potential miR-181a pairing sites in functionally relevant candidate genes using an unpublished computer program (J.C. and C.-Z.C., unpublished data). In brief, candidate mRNA sequences are broken into 40 nt overlapping fragments, and their ability to pair with miR181a is analyzed using the RNA folding program M-FOLD. Target sequences that form more stable pairing with self than with miR-181a are eliminated: in this way, our program takes into consideration the secondary structure of the target sites. Furthermore, single nucleotide mismatch and G:U base pairing in the seed region is tolerated, since these are features of many genetically validated target sites (Reinhart et al., 2000; Didiano and Hobert, 2006) . Both the coding regions and the untranslated regions (UTRs) of the candidate targets are analyzed.
Using this program, we found that the tyrosine phosphatases SHP-2 and PTPN22 and the ERK-specific phosphatases DUSP5 and DUSP6 each contain multiple putative miR-181a pairing sites ( Figure S6 ). Only DUSP6 was predicted as a miR-181a target by published computational methods (Krek et al., 2005; Lewis et al., 2005) . Those potential target sites with near-perfect seed pairing and/or the lowest calculated free energy of binding were selected for further validation using a luciferase reporter assay ( Figure S6 ). Fusion luciferase reporters bearing predicted target sequences from SHP-2, PTPN22, DUSP5, or DUSP6, respectively, were specifically repressed by miR-181a, but not by an miR-181a mutant ( Figure 3A) or miR-142 (data not shown). Furthermore, western blot 
miR-181a Represses Multiple Phosphatases in T Cells
(A) Effects of miR-181a and miR-181a mut expression on luciferase reporter constructs containing putative miR-181a target sites are shown as relative luciferase activity (normalized to the Rennilla control and compared to the control reporter vector). Representative analyses of four independent experiments are shown (relative luciferase activity ± SD, n = 3; student's t test, **: p < 0.01).
(B and C) miR-181a regulation of phosphatase expression at the protein and mRNA levels. (B) Relative protein levels were determined by densitometry and normalized to b-actin, the loading control.
(C) miRNA-181a effect on mRNA level of each target is shown as the relative level toward the control virus after normalization to b-actin. Representative results of three independent experiments are shown (relative mRNA level ± SD, n = 3).
revealed that SHP-2, PTPN22, DUSP5, and DUSP6 protein levels are quantitatively reduced by miR-181a, but not by an miR-181a mutant ( Figure 3B ). Finally, miR181a can also reduce the mRNA levels of the target genes in T cells as indicated by qPCR analyses ( Figure 3C ). These results suggest that miR-181a may directly repress the expression of multiple phosphatases.
miR-181a Expression Enhances the Basal Activation of TCR Signaling Molecules Downregulation of these phosphatases by miR-181a is likely to systematically reduce negative feedback at distinct steps of TCR signaling. PTPN22, a potent negative regulator immediately downstream of TCR (Hasegawa et al., 2004) , can dephosphorylate Lck and ZAP70 at the activating Y394 and Y493 within the kinase activation loops (Wu et al., 2006) . A gain-of-function variant of PTPN22 has been shown to reduce T cell sensitivity . Consistent with the role of PTPN22 as a negative regulator of Lck, we found an increase in Y394 phosphorylation of Lck in miR-181a T cells even before stimulation ( Figure 4A ). DUSP5 and DUSP6, which have different cellular localization, can specifically inactivate ERK1/2 by dephosphorylating the T202 and Y204 residues in the nucleus and cytosol, respectively (Theodosiou and Ashworth, 2002). SHP-2 was found to mediate negative costimulatory signals elicited by CTLA-4 (Marengere et al., 1996) , but it has not been shown to play any direct role in TCR proximal signaling (Salmond et al., 2005) .
To examine how miR-181a may affect ERK1/2 activation, we measured ERK1/2 T202 and Y204 phosphorylation (ppERK) levels before and after antagonist stimulation using intracellular antibody staining and FACS analysis (Krutzik and Nolan, 2003) . miR-181a T cells have a significantly higher level of ppERK prior to stimulation ( Figure 4B , blue lines). MCC 99R can stimulate ERK phosphorylation in miR-181a T cells ( Figure 4B ) or in DP thymocytes, which have a naturally high level of miR-181a ( Figure 7C ), but not in control T cells ( Figure 4B, orange lines) . Furthermore, we examined whether miR-181a may alter the kinetics of ERK phosphorylation during T cell activation. T cells were activated by CD33 crosslinking to avoid any contribution from costimulation. We noted that miR-181a T cells have a significantly higher basal level of ppERK before stimulation and a slightly higher peak level after stimulation ( Figure 4C ). While both the control and miR-181a T cells reached maximal levels within 15 min after stimulation, a delay in dephosphorylation was observed in miR-181a T cells. More importantly, ppERK in these cells returns to a higher basal level when compared to controls ( Figure 4C , time points 15-60 min). These data demonstrate that ERK phosphorylation is shifted to a higher basal level both before and after stimulation, suggesting that miR-181a induces decreases in phosphatase expression and acts to shift the equilibrium to higher steady-state levels of ppERK.
This increased basal level of ppERK may have additional effects in potentiating TCR proximal signaling as indicated by dramatic increases in serine phosphorylation of Lck in miR-181a T cells ( Figure 4D ). Restoring DUSP6 expression to a normal level by coexpressing miR-181a and a DUSP6 gene without the miR-181a target sites (Figure 6A ) reduces basal Lck serine phosphorylation to the background level ( Figure 4D) , suggesting that the downregulation of DUSP6 is directly responsible for the increase in Lck serine phosphorylation. While there are four major serine phosphorylation sites in Lck, activated ERK is responsible for Ser59 phosphorylation under physiological conditions (Winkler et al., 1993) . Germain and colleagues have proposed that positive feedback from ERK is crucial for agonists to overcome SHP-1 blockade and have shown that Ser59 phosphorylation of Lck can block SHP-1 recruitment (Stefanova et al., 2003) . In agreement with this observation, we noted a dramatic reduction in the recruitment of SHP-1 to Lck before and after antagonist stimulation in miR-181a T cells ( Figure 4E ). It is also notable that restoring DUSP6 expression in these cells results in a decrease in the basal level of Y394 phosphorylation on Lck, suggesting that blocking SHP-1 recruitment to Lck may also contribute to the increased basal level of this phosphotyrosine ( Figure 4A ). These observations suggest an alternative mechanism in which antagonistinduced SHP-1 negative feedback can be overcome or reduced despite the fact that SHP-1 is not directly targeted by miR-181a. Collectively, it seems that the increased basal level of Lck and ERK activation in miR-181a T cells reduces the amount of signal that is required for achieving full Lck and ERK activation upon antigen stimulation, thus reducing the activation threshold and increasing signaling strength to agonists and antagonists ( Figure S11 ).
Multitarget Regulation by miR-181a Is Crucial for Its Function
To determine whether one or all of the phosphatases regulated by miR-181a are functionally relevant for its conversion of antagonists into agonists, we designed short hairpin siRNAs (shRNAs) to selectively ''knock down'' SHP-1, SHP-2, DUSP5, and DUSP6 expression ( Figures 5A and  5B) . In each case, we were able to obtain shRNA constructs that can specifically repress target gene expression equally or more efficiently than miR-181a ( Figures  3B, 5A , and 5B). We then expressed individual shRNAs in T cells by viral transduction and challenged them with APCs preloaded with MCC 99R. We determined the calcium response and then categorized the signal strength using the typical response of control T cells toward MCC as a reference. As shown in Figure 5C , over 90% of miR-181a T cells yielded medium to strong responses when stimulated with MCC 99R, whereas less than 10% of the T cells infected with shRNAs against DUSP5, SHP-2, control shRNAs, or control virus ( Figure 5C ) responded this way, which represents the background levels. We noticed that shRNAs against SHP-1 and DUSP6 do have modest effects, with 25% and 38% of the T cells expressing shRNA yielding medium to strong responses, respectively. However, both the peak values and the degree to which calcium signaling is sustained are reduced even in these T cells when compared to the response in miR-181a T cells ( Figure S7 ). Taken together, these data demonstrate that repressing individual phosphatases is not sufficient to fully reproduce the miR-181a phenotype in T cells.
To evaluate whether downregulation of individual miR-181a targets is necessary for the increase in T cell sensitivity to antagonists, we restored DUSP6 expression to normal levels in miR-181a T cells by expressing a DUSP6 gene that lacks the miR-181a target sites (Figure 6A) . This resulted in a reduction in the basal level of (E) miR-181a expression inhibits the Lck and SHP-1 interaction. T cells were stimulated by peptide preloaded APCs (10mM MCC 99R or 1mM MCC) for 5 min. SHP-1 was coprecipitated with Lck whereas SHP-2 was undetectable under the same condition.
ppERK ( Figure 6B , time point zero) and accelerated ERK dephosphorylation/inactivation ( Figure 6B , time points 10-60 min). Most importantly, restoring DUSP6 expression in this way completely abolishes T cell reactivity to MCC 99R ( Figures 6C, 6D , and 6E; Movie S6). Similarly, restoring DUSP5 expression in the nucleus ( Figure S8A ) results in a dramatic reduction in the IL-2 production induced by MCC 99R, while it has little effect on cytosolic calcium responses (Figures 6D and 6E ; Movie S7), suggesting that wild-type DUSP5 acts as a negative regulator controlling IL-2 production in the nucleus with little impact on immediate early TCR signaling. Interestingly, expressing and sequestering DUSP5 protein in the cytosol by nuclear localization signal mutation (Mandl et al., 2005) largely resembles the TCR sensitivity shift caused by restoring DUSP6 ( Figures 6D and 6E ). These data collectively suggest that the cytosolic level of ERK activation may be crucial for initial TCR signaling upon antigen recognition. In contrast, restoring SHP-2 ( Figure S8B ) does not change the basal level of Lck activation ( Figure 4A) or suppress the recognition of MCC 99R, although it does cause a modest reduction in TCR signaling strength ( Figure 6D ; Movie S8), suggesting that SHP-2 plays a minor role in antigen discrimination. These results demonstrate that the TCR signaling threshold is controlled by multiple phosphatases at distinct steps of the downstream pathways, albeit with varied contributions to the threshold.
Antagomir-181a Dampens T Cell Sensitivity and Impairs Positive and Negative Selection
The above results clearly show that increasing miR-181a levels in mature T cells by ectopic expression augments T cell sensitivity. To test whether reducing the level of endogenous miR-181a affects T cells reciprocally, we used antagomir-antisense oligos that silence miRNA expression in vivo (Krutzfeldt et al., 2005) -to reduce miR-181a expression. We find that antagomir-181a significantly lowers naïve T cell sensitivity to MCC and MCC 102S, as indicated by calcium flux and IL-2 production (Figures Reducing miR-181a expression also dampens T cell sensitivity to weak stimulation in primed T cells, albeit to a lesser degree than that in naïve cells ( Figures S9D and  S9E ). The smaller reduction in antigen sensitivity in primed T cells is probably because the miR-181a level in these cells ($10 copies/cell) is much lower than that in the naïve T cells ($30 copies/cell) ( Figure 1A ). Finally, a maximal response to the agonist MCC can be induced at a loading concentration close to the peptide: MHC K d in naïve T cells ( Figure S9B ), while much higher concentrations are required to elicit a maximal response in primed T cells, suggesting that naïve T cells are more sensitive to antigen, consistent with recent peptide response studies (M. Huse, M.Kuhns, and M.D., unpublished data). miR-181a expression is dynamically regulated during T cell development, with immature DP cells having a $10-fold higher expression of miR-181a than their mature counterparts ( Figure 1A ). This higher miR-181a expression correlates with heightened sensitivity toward pMHC ligands in DP cells, which is thought to be critical in ensuring proper positive and negative selection, and shaping of the mature T cell repertoire (Davey et al., 1998) . Consequently, we tested miR-181a function in DP cell selection using fetal thymic organ culture (FTOC) with or without antagomir treatment. We crossed 5C.C7 TCR transgenic mice onto an invariant chain knockout (IiÀ/À) background (Bodmer et al., 1994) to arrest thymocytes at the DP stage. Presenting exogenous 5C.C7 TCR antigens, such as agonist (MCC), weak agonist (MCC 102S, data not shown), or antagonist (MCC 99R), can induce efficient negative selection within 48 hr, and introducing antagomir-181a to these cultures results in a greater than 50% inhibition (Figure 7A) . Although a moderate increase in the DN cell population was observed, antagomir-181a treatment did not affect the viability of DP thymocytes in this culture system ( Figure 7A ; data not shown). To examine the role of miR181a in positive selection, we used thymi from wild-type 5C.C7 embryos. These mice have normal invariant chain production and are capable of presenting endogenous peptide antigens, thus allowing positive selection. Dampening miR-181a expression with the antagomir-181a reagent substantially impairs positive selection, reducing the number of mature CD4 + SP thymocytes by $70% (Figure 7B) . Further confirming that the miR-181a level in thymocytes plays a critical role in their activation, the responsiveness of 5C.C7 DP cells to MCC and MCC 102S, as indicated by CD69 expression, was almost abolished by treatment with 50 mg/ml antagomir-181a ( Figure S10A ).
With respect to the mechanism of this inhibition in thymocytes, all miR-181a-targeted phosphatases are expressed in DP cells, and antagomir-181a treatment increases the mRNA and protein levels of PTPN22, SHP-2, DUSP5, and DUSP6 ( Figures S10B and S10C) . Consistent with the increased expression of those phosphatases in antagomir-181a treated DP cells, we observed a severe reduction of ERK activation both in basal level ( Figure 7C ; time 0) and antigen-induced phosphorylation ( Figure 7C ; time 5 0 to 60 0 ). Collectively, these results demonstrate that antagomir-mediated reduction of miR-181a expression in immature DP cells attenuates their sensitivity to antigen and inhibits positive and negative selection. Thus, miR-181a is an intrinsic modulator of TCR sensitivity during T cell development and function.
DISCUSSION
Our studies demonstrate that TCR sensitivity and signaling strength can be modulated at the posttranscriptional level by miR-181a. These findings have a number of implications for both the regulation of the adaptive immune response and the biology of miRNAs. In particular, these data suggest that miR-181a is a rheostat governing T cell sensitivity. It is known that the same antigenic peptides elicit distinct TCR signals and responses in T cell populations at different developmental stages, suggesting that T cell sensitivity to antigens is intrinsically regulated (Pircher et al., 1991; Davey et al., 1998) . Properly tuning T cell sensitivity at various developmental stages may be critical for regulating the development of tolerance and effector cell function. miR-181a expression is higher in immature T cell populations that recognize low-affinity selfantigens, such as DP thymocytes, but lower in the more differentiated T cell populations that are only reactive to relatively high-affinity foreign antigens, such as Th1 and Th2 effector cells ( Figure 1A ). The inhibition of this miRNA by antagomor-181a significantly impairs DP cell sensitivity and efficiently obstructs positive and negative selection, supporting the notion that miR-181a is developmentally regulated to refine T cell sensitivity. Interestingly, miR181a is also highly expressed in DN3 cells that are undergoing the selection driven by self oligomerization of preTCRs (Yamasaki et al., 2006) , which is presumably a weak stimulation that miR-181a may help to potentiate. The modulation of selection also argues that miR-181a might directly impact the mature T cell repertoire, which might further affect the onset and/or progression of T cell autoimmunity. Together, these results demonstrate that miRNAs may represent a novel class of regulatory activation in control cells, and the brown line indicates the full activation level of ERK in control T cells upon TCR activation. In (C) are overlaid DIC and calcium images taken at various time points after T cells ectopically expressing miR-181a alone (top panel) or miR-181a and DUSP6 together (lower panel) were stimulated with APCs preloaded with MCC 99R (20 mM). Shown in (D) is cytosolic calcium concentration as a function of time in T cells ectopically expressing miR-181a alone or miR-181a together with individual target phosphatases. Shown in (E) is the effect of individual target restoration on IL-2 production. Virally infected and selected T cells were set to rest after initial preparation, then cocultured with g-irradiated APCs preloaded with either MCC 99A (20 mM), MCC 99R (10 mM), or MCC 102G (20 mM). Supernatants were collected at 24 hr after stimulation and analyzed for IL-2 production by ELISA ([IL-2] ± SD, n = 3).
Figure 7. miR-181a Modulates Positive and Negative Selection
(A) Antagomir-181a (Ant181a) impairs negative selection. E17 fetal thymi from 5C.C7 TCR transgenic mouse embryos on an IiÀ/À B10BR background were used to set up FTOC assays. Antagomir-181a (50 mg/ml) or PBS mock control was applied upon initiation of the culture. MCC (100 nM), MCC 99R (5mM), or PBS was introduced 24 hr later. Cultured thymi were analyzed 48 hr after peptide application. Representative data of six independent replicates are shown. (B) Antagomir-181a impairs positive selection. FTOC was performed with thymi dissected from e15 or e16 5C.C7 wild-type embryos (absent of SP cells, data not shown) and antagomir-181a (50 mg/ml) or the mock control was applied upon culture initiation. Thymocytes were analyzed 4-5 days later. CD69 and CD62L staining was also used to verify the postselection phenotype of SP cells (data not shown). Representative data of six replicates are shown. (C) Antagomir-181a inhibits ERK activation in DP thymocytes. DP cells prepared from the thymus of adult 5C.C7 IiÀ/À mice were stimulated with CH27 cells served as APC loaded with 10 mM MCC 99R (green/red) or PBS (gray).
molecules that can modulate T cell sensitivity. However, we do not exclude the possibility that other TCR signaling components or other miRNAs may also contribute to changes in sensitivity.
Our findings also provide new insights into the signaling pathways that determine how TCRs sense quantitative differences in antigen affinity and elicit quantitatively and qualitatively different responses, and how such responses may be intrinsically tuned. These observations suggest that the TCR and its proximal signaling molecules act as a ''signal integrator'' to sum up the positive and negative signals elicited by antigen stimulation, thus determining the outcome of TCR engagement. It is known that, in general, longer half-life pMHC ligands elicit stronger positive signals. We find here that the negative feedback signals in this pathway, controlled in part by multiple phosphatases downstream of the TCR, play a key role in regulating TCR signaling and antigen discrimination, suggesting that they set an ''excitation threshold'' for T cell activation, in which negative regulation is likely to be dominant. Supporting this, primed T cells normally cannot be activated by antagonist pMHCs (Figures 2 and 4) , suggesting that these ligands cannot generate sufficient positive signals to overcome the excitation threshold. However, when the equilibrium is shifted toward a higher steady state of phosphorylated signaling intermediates (ERK1/2, Lck as shown above) by ectopically expressing miR-181a (Figure 2 and 4) , these ligands are now stimulatory, and weak agonists are now strongly activating ( Figure S11 ).
One would also predict that dampening these negative signals should lead to an increase in TCR signaling strength, since the degree of positive signaling required for overcoming the excitation threshold is also reduced. Indeed, we have shown that antagonist, or weak agonist, or agonist I-E k complexes have increased signaling strength in miR-181a T cells, albeit at quantitatively different levels (Figures 1 and 2 ). Our findings also suggest two avenues that can be used to overcome this excitation threshold and to activate T cells. One is by reducing the excitation threshold such that it can be overcome by the otherwise insufficient positive signals generated from a particular weak antigen. Alternatively, weak positive TCR signals may be potentiated so that the excitation threshold can be overcome. Finally, our finding that antagonists can be converted into agonists shows that even antagonists can bind to the TCR long enough to complete the entire TCR signaling cascade when the threshold is reduced. Many biological processes are controlled at the systems level by coordinated regulation of networks of genes. Specifically, TCR signaling and antigen recognition are controlled by sequential phosphorylation and dephosphorylation events in a spatially and temporally ordered manner (Kane et al., 2000) . T cells express more than 40 different tyrosine phosphatases and other known or unknown negative regulators of TCR signaling (Mustelin et al., 2005) . There are multiple phosphatases for each of the key kinases, such as Lck, ZAP70, ERK, etc. (Mustelin et al., 2005) . Tuning a T cell's excitation threshold presents a particular challenge because of the many signaling molecules that seem to constitute the threshold. It may require the coordinate regulation of multiple negative regulators that share little or no sequence homology. Our findings demonstrate that this task can be carried out very efficiently by a single miRNA, which can regulate multiple targets, but not by a single shRNA, which is designed to target individual genes. This is consistent with the notion that each miRNA can potentially regulate hundreds of targets (Krek et al., 2005; Lewis et al., 2005) . Nevertheless, the function of most miRNAs with known biological roles has been attributed to the regulation of a single target gene (Ambros, 2003) , and the biological significance of multitarget regulation by miRNAs in signaling is unclear. We have also shown that the expression of PTPN22, SHP-2, and DUSP6 are only modestly reduced by miR-181a (Figure 3 ), suggesting that quantitative regulation is sufficient to allow a discriminative switch during antigen recognition. Finally, we have noted that miR-181a is likely to have other roles in T cell function, since it also influences the costimulatory pathway through as yet unknown targets ( Figure S4 ). Collectively, our findings suggest that miRNAs may be evolutionarily selected gene-regulatory molecules that can carry out integrated biological functions by regulating gene networks posttranscriptionally .
EXPERIMENTAL PROCEDURES
Details of standard techniques, mouse strains, antibodies used, and sequences can be found in the Supplemental Experimental Procedures.
T Cells and APCs
T cells were harvested from the lymph nodes of 5C.C7 mice and primed with 10 mM MCC peptide. A day after priming, T cells were transduced with retroviral miRNA expressing constructs ( Figure S2 ). Infected T cells were first subjected to blasticidin (12.5 mg/ml, Invitrogen) selection for 2 days starting at 36 hr postinfection, further enriched by density gradient centrifugation with Histopaque-1119 (Sigma-Aldrich), and finally purified based on H-2K b expression by magnetic bead sorting according to the manufacturer's protocol (Biotinylated anti-H-2K b , 10 mg/ml, BD Pharmingen; CELLection Biotin Binder Kit, Dynal Biotech). With this procedure, infected T cells were enriched to at least 95% purity based on FACS analyses (data not shown). Peptide-loaded CH27 cells, a mouse B lymphoma cell line, were used as antigen presenting cells in this study.
Quantitative PCR for miRNA Expression Analysis
The ABI TaqMan miRNA assays were used to measure miR-181a expression in various T cell populations (Chen et al., 2005) . Purified T cells were spiked with a synthetic miRNA standard at a fixed ratio of pmol/cell. Total RNA samples were then prepared using Trizol reagents. miRNA expression in each cell population was determined using standard curve methods following the ABI TaqMan miRNA quantitative PCR protocol.
Multichannel Time-Lapse Microscopy and Data Analysis
Calcium imaging and synaptic peptide quantification were performed on a Zeiss Axiovert-100TV station equipped with a CoolSNAP HQ CCD camera (Roper Scientific) as described , also in Supplemental Experimental Procedures. The data points were pooled from four batches of primary cell preparation. For calcium dynamics and concentration integration analysis in activated T cells, time 0 was defined as the time point prior to the first 20% increase of ratioed fluorescent intensity, then the base line (value = 1.00) was drawn by averaging the intensity before time 0. In inactive T cells, time 0 was arbitrarily assigned as the T:APC contact point observed in the differential interference contrast (DIC) channel. The integrated value of cytosolic calcium elevation was generated by summing up the changes in relative calcium concentration at each time point within the first 5 min of T cell calcium response.
Luciferase Reporter Assay for Target Validation NIH-3T3 cells stably expressing miR-181a on miR-181a mut were generated by viral transduction and multiple rounds of blasticidin selection and then transfected with 0.1 mg of firefly luciferase reporter vector together with 0.025 mg of control Renilla luciferase control vector (see Figure S2B ) using FuGene 6 reagents (Roche). Cells were lysed at 48 or 72 hr after transfection and analyzed for firefly and Renilla luciferase activities using the Dual-Luciferase Assays (Promega) on a Veritas Microplate Luminometer.
Antagomir Treatment Antagomirs were synthesized as described (Krutzfeldt et al., 2005) . For naïve T cell transfection, cells were cultured for 16 hr in the presence of 5 ng/ml IL-7 and 50 mg/ml antagomir-181a or Mm-antagomir-181a; for DP thymocyte transfection, cells were cultured in RPMI medium for 12 hr in the presence of various amounts of antagomir-181a.
Fetal Thymic Organ Culture
Thymi were dissected from e15 embryos of 5C.C7 TCR mice or e17 embryos of 5C.C7 TCR Ii À/À mice. Fetal thymi were cultured on 0.8 micron filters (Millipore) and MF support pads (Millipore) floated on RPMI culture medium. Antagomirs were added to thymi at a final concentration of 50 mg/ml on day 0 of culture, antigenic peptides were added on day 1, and single cell suspensions were prepared for FACS analysis on days 3-5.
Phosphoflow Analysis
Phosphoflow technology was used to monitor T202 Y204 phosphorylation of ERK1/2 (ppERK) (Krutzik and Nolan, 2003) . Briefly, virally infected T cells were mixed with CH27 cells alone or CH27 cells preloaded with 10 mM MCC 99R, spun down to facilitate rapid T:APC contact, incubated at 37 C for 5 min or with anti-CD33 crosslinking at various time points, and fixed with 2% paraformaldehyde at room temperature for 20 min. After washes with ice-cold FACS buffer (PBS pH 7.4, 2mM EDTA, 2% FBS), T cells were blocked with anti-CD16/CD32 (10 mg/ml) for 15 min on ice and stained with fluorescent antibodies against the cell surface markers CD4, CD28, etc. After being washed three times with FACS buffer, T cells were suspended in 90% ice-cold methanol and kept on ice for 30 min to allow for permeabilization. One million permeabilized cells were further blocked by anti-CD16/CD32 and species-matched serum, stained with phosphor-specific ERK antibody, and analyzed by FACS (Cytomics FC500, Beckman Coulter). FACS data was analyzed with FlowJo software (Tree Star, Inc.). The ppERK staining results were repeated with an indirect staining approach using anti-ppERK rabbit monoclonal antibody (Cell Signaling Technology), followed by donkey Cy5-anti-rabbit IgG staining (Jackson ImmunoResearch) and FACS analysis.
Supplemental Data
Supplemental Data include 11 figures, 8 movies, and Supplemental Experimental Procedures and can be found with this article online at http://www.cell.com/cgi/content/full/129/1/147/DC1/.
